My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vivos Therapeutics, Inc. - Common Stock (NQ:VVOS)

3.570 +0.130 (+3.78%)
Streaming Delayed Price Updated: 11:40 AM EDT, Sep 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vivos Therapeutics, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Present at Benzinga Global Small Cap Conference
Via Investor Brand Network
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Showcasing Innovations in OSA Treatment at 2021 Annual Breathing Wellness Conference
Via Investor Brand Network
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS), Candid to Bring Airway and Sleep, Oral Health, Orthodontic Therapy Together in Comprehensive Solution
Via Investor Brand Network
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS), Candid Collaborate to Deliver Comprehensive Treatment Solution
Via Investor Brand Network
BioMedNewsBreaks – Vivos Therapeutics Inc.’s (NASDAQ: VVOS) Guides Demonstrate Significant Reduction of Pediatric Tooth Decay in Peer-Reviewed Study
Via Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Revance Therapeutics (NASDAQ:RVNC) stock moved upwards by 17.79% to $24.09 during Wednesday's pre-market session. The company's market cap stands at $1.7... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Geovax Labs (NASDAQ:GOVX) shares increased by 23.44% to $5.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $32.6... 
Via Benzinga
16 Stocks Moving in Wednesday's Pre-Market Session
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) rose 29.7% to $5.42 in pre-market trading after the company reported the purchase of exclusive rights to PNP Therapeutics'... 
Via Benzinga
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Forms Medical Consortium to Advance OSA Technology
Via Investor Brand Network
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Present at Benzinga Healthcare Small Cap Conference
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Present at Benzinga Healthcare Small Cap Conference
Via Investor Brand Network
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Larimar Therapeutics (NASDAQ: 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Triple-S Management (NYSE:GTS) shares moved upwards by 45.3% to $35.15 during Tuesday's regular session. As of 12:30 EST, Triple-S Management's stock is... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield... 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide
Midway through trading Tuesday, the Dow traded up 0.09% to 35,368.20 while the NASDAQ rose 0.40% to 15,001.95. The S&P also rose, gaining 0.14% to 4,486.01. The U.S. has the... 
Via Benzinga
Topics Stocks
38 Stocks Moving In Tuesday's Mid-Day Session
Gainers Triple-S Management Corporation (NYSE: GTS) shares jumped 45.3% to $35.15. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield of Florida Inc,... 
Via Benzinga
Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates
Following the market opening Tuesday, the Dow traded up 0.11% to 35,374.12 while the NASDAQ rose 0.43% to 15,006.17. The S&P also rose, gaining 0.22% to 4,489.23. The U.S. has... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Triple-S Management (NYSE:GTS) stock moved upwards by 44.27% to $34.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) rose 48.3% to $0.777 in pre-market trading after gaining over 3% on Monday. The company, earlier during the month, reported downbeat... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,... 
Via Benzinga
Mid-Afternoon Market Update: Dow Gains 270 Points; Vivos Therapeutics Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.77% to 35,392.00 while the NASDAQ rose 1.64% to 14,956.54. The S&P also rose, gaining 1.01% to 4,486.66. The U.S. has the... 
Via Benzinga
Topics Stocks
Nasdaq, S&P 500 Notch Intraday Highs Amid Fresh Economic Data
The Dow Jones Industrial Average is up 271 points at midday, extending this morning's gains as investors speculate on this week's annual Jackson Hole monetary policy symposium. 
Via Talk Markets
Topics Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Vivos Therapeutics (NASDAQ:VVOS) stock rose 45.44% to $5.58 during Monday's regular session. As of 12:30 EST, Vivos Therapeutics's stock is trading at a... 
Via Benzinga
Mid-Day Market Update: Crude Oil Surges 5%; Staffing 360 Solutions Shares Plunge
Midway through trading Monday, the Dow traded up 0.77% to 35,391.72 while the NASDAQ rose 1.35% to 14,912.95. The S&P also rose, gaining 0.95% to 4,484.08. The U.S. has the... 
Via Benzinga
Topics Stocks
35 Stocks Moving In Monday's Mid-Day Session
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value... 
Via Benzinga
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives FDA Clearance For mmRNA Oral Appliance
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering... 
Via Benzinga
VVOS Stock: The Sleep Apnea Device News That Is Waking Up Vivos Therapeutics Shares
Vivos Therapeutics (VVOS) stock is taking off on Monday morning after revealing clearance from the FDA for its sleep apnea device. 
Via InvestorPlace
Mid-Morning Market Update: Markets Open Higher; Pfizer To Acquire Trillium Therapeutics
Following the market opening Monday, the Dow traded up 0.56% to 35,318.36 while the NASDAQ rose 0.90% to 14,847.67. The S&P also rose, gaining 0.64% to 4,469.94. The U.S. has... 
Via Benzinga
Topics Stocks
Why Vivos Therapeutics Shares Are Soaring Today
Vivos Therapeutics (NASDAQ: VVOS) is surging higher today after the company announced the U.S. Food and Drug Administration granted 510(k) market clearance to its mmRNA... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Vivos Therapeutics (NASDAQ:VVOS) stock increased by 64.84% to $6.33 during Monday's pre-market session. The market value of their outstanding shares is at $144... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.